¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25
±³À°ÀÏÀÚ : 2021-09-25
±³À°Àå¼Ò : ¿Â¶óÀÎ (½Ç½Ã°£ È­»ó °­ÀÇ)  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇÑÀçÈ°ÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÓ»óÅëÁõÇÐȸ  
´ã´çÀÚ : ´ëÇÑÀÓ»óÅëÁõÇÐȸ
¿¬¶ôó : 02-958-8567  
À̸ÞÀÏ : kapainmed@hanmail.net      
±³À°Á¾·ù : ÀçÈ°ÀÇÇаú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 60,000¿ø      
ºñ°í Àü¹®ÀÇ »çÀüµî·Ï: 60,000¿øÀü°øÀÇ »çÀüµî·Ï: 40,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 09:30~10:00 Recent updates on diagnosis and treatment of RA and SpA: Guideline review  ¹æ¼Ò¿µ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 10:00~10:30 Radiologic assessment of RA and SpA  °­¿ì¿µ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 10:30~11:00 Recent updates on pharmacologic treatment for RA and SpA  Á¤»óÀ±(Â÷ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 11:00~11:30 PMR physician¡¯s view: case-oriented clinical practice of RA and SpA  ±èµÎȯ(Áß¾ÓÀÇ´ë) 
Åä·Ð 09-25  11:30~11:40 Q&A  () 
±âŸ 09-25 ½Ç½Ã°£ 11:40~12:00 Á¦22Â÷ Á¤±âÃÑȸ  () 
½Ä»ç 09-25  12:00~13:00 Lunch  () 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 13:00~13:30 New concepts, phenotypes and critical aggravating factors of OA  ÀÌÀνÄ(°Ç±¹ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 13:30~14:00 Recent updates and clinical experiences on pharmacologic treatment of OA  Àå¹Îö(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 14:00~14:30 Interventional and surgical treatment for osteoarthritis: update and review  ¿ÕÁØÈ£(¼º±Õ°üÀÇ´ë) 
Åä·Ð 09-25 ½Ç½Ã°£ 14:30~15:00 Coffee break  () 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 15:00~15:30 Treatment strategies for immunosuppressive/immunomodulatory agents  ÀÌÀº¿µ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 15:30~16:00 Exercise for inflammatory/degenerative arthropathy: how? How much?  ¹Î°æÈÆ(Â÷ÀÇ´ë) 
±³À°½Ã°£ 09-25 ½Ç½Ã°£ 16:00~16:30 Safety issues that should be considered in pharmacologic treatment:pregnancy, COVID-19 vaccination, other immunotherapy  ¼­Ã¢Èñ(¾ÆÁÖÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021³â ´ëÇÑÀÓ»óÅëÁõÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÀå³»½Ã°æÀ» À§ÇÑ ÀåÁ¤°áÁ¦°¡ ¾ó¸¶³ª ¹ßÀüÇßÀ»±î? : 2021-09-25
´ÙÀ½±Û 2021³â Á¦ 10Â÷ ´ëÇÑôÃßÁ¾¾çÇÐȸ Ãß°èÇмú´ëȸ : 2021-09-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20605 ´ë±¸ ´ëÇÑ»êºÎÀΰúÇÐȸ ´ë±¸Áöȸ ¿¬¼ö°­Á : 2024-06-20 0 36 2024-04-29
20604 °­¿ø Á¦171ȸ ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø ¼ÒÈ­±â ¿¬¼ö±³À° : 2024-06-19 0 40 2024-04-29
20603 °æ±â Á¦16ȸ ±¹¸³¾Ï¼¾ÅÍ ±¹Á¦½ÉÆ÷Áö¾ö : 2024-06-19 0 44 2024-04-29
20602 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16 0 41 2024-04-29
20601 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-06-16 0 32 2024-04-29
20600 ¼­¿ï 2024 Á¦ 2ȸ ¿¬¼¼´ëÇб³ ¼öºÎ ¹× »óÁö ½ÉÆ÷Áö¾ö : 2024-06-16 0 29 2024-04-29
20599 ¼­¿ï ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2024 »êºÎÀΰú¹Ì¼º³â¿¬¼ö°­Á : 2024-06-16 0 43 2024-04-29
20598 ±¤ÁÖ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ È£³² ¹× Á¦ÁÖ ¿¬¼ö°­Á : 2024-06-16 0 28 2024-04-29
20597 ¼­¿ï À¯¹æ ÃÊÀ½ÆÄ °Ë»ç ÀÔ¹® ±³À°: °­ÀÇ ¹× ½Ç½À : 2024-06-16 0 24 2024-04-29
20596 ¼­¿ï ´ëÇÑ°ñ´ë»çÇÐȸ SSBH 2024 (The 12th Seoul Symposium on Bone Health)&Á¦36Â÷ Ãá°èÇмú´ëȸ 3ÀÏÂ÷ : 2024-06-15 0 26 2024-04-29
20595 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 3ÀÏÂ÷ : 2024-06-15 0 24 2024-04-29
20594 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼ÛÆı¸ÀÇ»çȸ Ãá°è ¿Â¶óÀÎ Çмú´ëȸ (6¿ù) : 2024-06-15 0 49 2024-04-29
20593 ´ë±¸ ´ëÇѵΰæºÎ¿Ü°úÇÐȸ Daegu Head and Neck Ultrasound Symposium : 2024-06-15 0 18 2024-04-29
20592 ºÎ»ê 2024³â ºÎ»ê¿Ü°úÇÐȸ Ãá°è Çмú´ëȸ : 2024-06-15 0 23 2024-04-29
20591 ´ë±¸ ´ëÇѼҾƽÉÀåÇÐȸ Á¦15ȸ ¼Ò¾ÆÆ󵿸ưíÇ÷¾Ð ½ÉÆ÷Áö¿ò : 2024-06-14 0 36 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷